http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114391044-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e3d2155686172ad1bfa3e552d8c7ad0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f27bcaaf6df6890511d32818d0e1a12b |
| publicationDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114391044-A |
| titleOfInvention | Method for confirming the propensity to form hematological tumors |
| abstract | The present invention relates to the field of confirmation and prevention of the predisposition to develop clinical manifestations of CLL based on mutations in specific genes for the formation of the B cell receptor (BCR). To confirm this tendency, the allele of the IGVL3-21 gene, ie the allele IGVL3-21*01, was confirmed by sequencing or PCR or other suitable methods. |
| priorityDate | 2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.